Skip to content

NEOPHYTE

Active Private limited companyfounded 2024active for 2 yearsBoulevard Piercot 6, 4000 LiègeKBO/BCE: BE 1015.193.486

Lifetime

2 annual accounts with figures on one time axis
peak of €70,171 in 2025
€70,171▲ 326%
peak of €55,101 in 2025
€55,101▲ 325%
peak of €70,568 in 2025
€70,568▲ 356%
€19,441▲ 125%
Board1 name since 2024
1 director
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Gross margin from €16,457 to €70,171Result from €12,967 to €55,101Equity from €15,467 to €70,568Debts from €8,656 to €19,441Cash from €6,801 to €56,689

Key points

from the 2025 annual accounts

Equity

€70,568 ▲ 356%
€15,5002024€70,6002025

Equity rose in 2025 from €15,467 to €70,568.

Turnover

≈ €210,000 estimated

The micro format states no turnover.

Liquidity

4.63 was 2.79 in 2024

Short-term debts rose from €8,656 to €19,441.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as NEOPHYTE has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for NEOPHYTE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 18-10-2024
Board & ownership

Recent changes

Incorporation Founding capital of €2,500, 100 shares · appointed as director · acts as permanent representative · published on 18-10-2024 · Gazette deed
First establishment Boulevard Piercot 6, Liège
All 4 events

Official details

Source: KBO
Status
Active since 16-10-2024Normal situation
Activity
“La société a pour objet l'exercice de la médecine par le ou les actionnaires…” (deed in French)From the articles, 3 activities1 activity on the establishment unit
Establishment unit
2.365.656.5864000 Liège, since 16-10-2024
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€90,009▲ 273%
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on NEOPHYTE

NEOPHYTE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €70,568 and a net result of €55,101.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEOPHYTE

What is the company number of NEOPHYTE?
The company number of NEOPHYTE is 1015.193.486. The VAT number is the same number with BE in front: BE 1015.193.486.
Where is NEOPHYTE based?
The registered office is at Boulevard Piercot 6, 4000 Liège.Company details
What is the legal form of NEOPHYTE?
NEOPHYTE is a private limited company (BV).
When was NEOPHYTE founded?
NEOPHYTE was founded on 16-10-2024.
Is NEOPHYTE still active?
Yes, NEOPHYTE is an active enterprise in the KBO register.
What is the turnover of NEOPHYTE?
The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €70,171 and 2,982 comparable companies of the same size. It probably lies between €140,000 and €360,000. It is a rough estimate.Financials
Is NEOPHYTE profitable?
In financial year 2025, NEOPHYTE made a profit of €55,101.
Where can I find the annual accounts of NEOPHYTE?
NEOPHYTE filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEOPHYTE due?
NEOPHYTE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.